Results 201 to 210 of about 151,776 (275)

Longitudinal Economic Burden for Non-Muscle-Invasive Bladder Cancer by EAU Progression Risk Groups Using the Prospective Multicenter COBLAnCE Cohort Linked to the French National Healthcare System Database. [PDF]

open access: yesEur Urol Open Sci
Fraslin AM   +22 more
europepmc   +1 more source

Hybrid grading systems improve progression risk stratification in non‐invasive papillary urothelial carcinoma and support a histomorphological continuum of disease progression

open access: yesHistopathology, Volume 89, Issue 6, Page 1064-1082, December 2026.
Hybrid grading systems significantly improve progression‐risk stratification in non‐invasive papillary urothelial carcinoma compared with the WHO 2004/2016 binary classification, with most benefit achieved by a Hybrid 3‐Tier framework. These findings support the existence of a histomorphological continuum of progression risk within the conventional ...
Jane K Nguyen   +16 more
wiley   +1 more source

Comment on: ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer. [PDF]

open access: yesEur Respir J
Rossi SH   +9 more
europepmc   +1 more source

From identity to caring: A 44‐country examination of the role of global social identifications in concern for global issues

open access: yesPolitical Psychology, Volume 47, Issue 6, December 2026.
Abstract Previous research suggests that people who identify with global communities tend to show greater concern for global challenges. Using student samples from 44 countries across different cultural clusters (N = 13,055), we examined whether (1) three forms of dispositional global social identification (GSI, with all humanity, citizens of the world,
Marta Penczek   +69 more
wiley   +1 more source

Dysphagia as the Initial Manifestation of Anti-HMGCR Antibody-Positive Immune-Mediated Necrotizing Myopathy Complicated by Pulmonary Embolism. [PDF]

open access: yesCase Rep Rheumatol
Kalluri R   +10 more
europepmc   +1 more source

Biomarker use in the prostate cancer screening pathway: Maps of the evidence

open access: yesCancer, Volume 132, Issue 22, 15 November 2026.
Abstract Prostate‐specific antigen (PSA)–based screening provides limited information about which individuals may harbor clinically significant prostate cancer (csPCa) and benefit from biopsy; tools such as magnetic resonance imaging (MRI) and biomarkers are being evaluated to improve risk stratification.
Rita L. Shiau   +4 more
wiley   +1 more source

MRI-derived features reveal recurrence heterogeneity in VI-RADS 2 non-muscle-invasive bladder cancer. [PDF]

open access: yesFront Oncol
Sun J   +11 more
europepmc   +1 more source

The impact of 5‐alpha reductase inhibitors on multiparametric MRI diagnostic performance and prostate‐specific antigen density triage: A systematic review

open access: yesBJUI Compass, Volume 7, Issue 11, November 2026.
Abstract Objectives To evaluate the impact of 5‐alpha reductase inhibitor (5‐ARI) exposure on multiparametric MRI (mpMRI) diagnostic performance for clinically significant prostate cancer (csPCa) and to assess whether standard prostate‐specific antigen density (PSAD)‐gated biopsy thresholds remain safe in this population.
Gregory Harrison   +4 more
wiley   +1 more source

An Aggregation-Induced Polymerization Poly(Disulfide)-Drug Nanoplatform for Autoimmune Uveitis Therapy via Inhibiting the cGAS-STING Pathway. [PDF]

open access: yesAdv Sci (Weinh)
Wu Y   +12 more
europepmc   +1 more source

PEDF alleviates autoimmune uveitis and reprograms Treg metabolism. [PDF]

open access: yesJ Neuroinflammation
Zhang Z   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy